Literature DB >> 10566945

Retention of cleaved synaptosome-associated protein of 25 kDa (SNAP-25) in neuromuscular junctions: a new hypothesis to explain persistence of botulinum A poisoning.

D A Raciborska1, M P Charlton.   

Abstract

Botulinum neurotoxins can block neurotransmitter release for several months. The molecular mechanism of these toxins' action is known, but the persistence of neuromuscular paralysis that they cause is unexplained. At frog neuromuscular junctions, application of botulinum toxin type A caused paralysis and reduced the C-terminus immunoreactivity of SNAP-25, but not that of the remaining N-terminus fragment. Botulinum toxin type C caused paralysis and reduced syntaxin immunoreactivity without affecting that of SNAP-25. Co-application of botulinum A and C reduced syntaxin immunoreactivity, and that of both C and N termini of SNAP-25. Application of hydroxylamine to de-palmitoylate SNAP-25 resulted in a slight reduction of the immunoreactivity of SNAP-25 N terminus, while it had no effect on immunoreactivity of botulinum A cleaved SNAP-25. In contrast, application of hydroxylamine to nerve terminals where syntaxin had been cleaved by botulinum C caused a considerable reduction in SNAP-25 N-terminus immunoreactivity. Hence the retention of immunoreactive SNAP-25 at the neuromuscular junction depends on its interactions with syntaxin and plasma membrane. Persistence of cleaved SNAP-25 in nerve terminals may prevent insertion of new SNAP-25 molecules, thereby contributing to the longevity of botulinum A effects.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10566945

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  7 in total

1.  Dynamin inhibition blocks botulinum neurotoxin type A endocytosis in neurons and delays botulism.

Authors:  Callista B Harper; Sally Martin; Tam H Nguyen; Shari J Daniels; Nickolas A Lavidis; Michel R Popoff; Gordana Hadzic; Anna Mariana; Ngoc Chau; Adam McCluskey; Phillip J Robinson; Frederic A Meunier
Journal:  J Biol Chem       Date:  2011-08-05       Impact factor: 5.157

Review 2.  The blockade of the neurotransmitter release apparatus by botulinum neurotoxins.

Authors:  Sergio Pantano; Cesare Montecucco
Journal:  Cell Mol Life Sci       Date:  2013-06-11       Impact factor: 9.261

3.  Persistence of Botulinum neurotoxin inactivation of nerve function.

Authors:  Charles B Shoemaker; George A Oyler
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

4.  Targeting botulinum neurotoxin persistence by the ubiquitin-proteasome system.

Authors:  Yien Che Tsai; Rhyan Maditz; Chueh-ling Kuo; Paul S Fishman; Charles B Shoemaker; George A Oyler; Allan M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-07       Impact factor: 11.205

5.  Therapeutic efficacy of equine botulism antitoxin in Rhesus macaques.

Authors:  Shantha Kodihalli; Andrew Emanuel; Teresa Takla; Yi Hua; Charles Hobbs; Ross LeClaire; Denise C O'Donnell
Journal:  PLoS One       Date:  2017-11-22       Impact factor: 3.240

6.  A literature review on the efficacy and safety of botulinum toxin: an injection in post-stroke spasticity.

Authors:  Majid Ghasemi; Mehri Salari; Fariborz Khorvash; Vahid Shaygannejad
Journal:  Int J Prev Med       Date:  2013-05

Review 7.  Mechanisms of Botulinum Toxin Type A Action on Pain.

Authors:  Ivica Matak; Kata Bölcskei; Lidija Bach-Rojecky; Zsuzsanna Helyes
Journal:  Toxins (Basel)       Date:  2019-08-05       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.